Carpmaels & Ransford has once again been recognised as a leading patent firm in the Financial Times’ annual report on Europe’s leading patent law firms. Based on recommendations from over 3,300 clients and peers, the report ranks Europe’s most highly regarded firms for patent prosecution and patent strategy consultation.

Carpmaels & Ransford ranked highly across several sectors including Biotechnology, Food & Healthcare, and Chemistry & pharmacy, in which it was very frequently recommended, retaining a gold ranking. Our gold ranking in these categories further solidifies our position as leaders in the Healthcare and Life Sciences sectors. The firm was also ranked for IT & Software, Materials & Nanotechnology, and Mechanical Engineering.

The report provides further recognition of Carpmaels & Ransford’s continuing success, following our award nominations for both Managing IP EMEA and LMG Life Sciences EMEA.